Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Hovind

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
Danish Medical Bulletin|June 10, 2006
Initiation, progression and remission of diabetic nephropathyPeter Hovind
Current Hypertension Reports|September 10, 2002
Microalbuminuria in type 1 and type 2 diabetes mellitus: evidence with angiotensin converting enzyme inhibitors and angiotensin II receptor blockers for treating early and preventing clinical nephropathyHans-Henrik Parving, Peter Hovind
Clinical Physiology and Functional Imaging|February 6, 2010
Decreased leg glucose uptake during exercise contributes to the hyperglycaemic effect of octreotidePeter Hovind, Lene Simonsen, Jens Bülow
The New England Journal of Medicine|March 1, 2005
Telmisartan vs. enalapril in type 2 diabetesHans-Henrik Parving, Peter Hovind, Peter Rossing
Current Hypertension Reports|September 3, 2004
Remission and regression of diabetic nephropathyPeter Hovind, Lise Tarnow, Hans-Henrik Parving
Ugeskrift for Laeger|May 19, 2011
[Glyceryl nitrates may cause hypertension]Peter Mørup, Tine Holbæk Levinsen, Peter Hovind
American Journal of Physiology. Cell Physiology|December 18, 2023
The GLP-1-mediated gut-kidney cross talk in humans: mechanistic insightGitte R Hinrichs, Peter Hovind, Ali Asmar
Ugeskrift for Laeger|March 31, 2023
Mads Fich Lønnee, Esben Andreas Carlsen, Peter Hovind
Diabetes Care|March 1, 2003
Smoking and progression of diabetic nephropathy in type 1 diabetesPeter Hovind, Peter Rossing, Lise Tarnow, et al.
Ugeskrift for Laeger|February 18, 2022
[Aksillør lymfeknudesvulst efter vaccination mod COVID-19]Rikke Bannebjerg Baarts Falkentoft, Mads Radmar Jensen, Peter Hovind
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
Danish Medical Bulletin|June 10, 2006
Initiation, progression and remission of diabetic nephropathyPeter Hovind
Current Hypertension Reports|September 10, 2002
Microalbuminuria in type 1 and type 2 diabetes mellitus: evidence with angiotensin converting enzyme inhibitors and angiotensin II receptor blockers for treating early and preventing clinical nephropathyHans-Henrik Parving, Peter Hovind
Clinical Physiology and Functional Imaging|February 6, 2010
Decreased leg glucose uptake during exercise contributes to the hyperglycaemic effect of octreotidePeter Hovind, Lene Simonsen, Jens Bülow
The New England Journal of Medicine|March 1, 2005
Telmisartan vs. enalapril in type 2 diabetesHans-Henrik Parving, Peter Hovind, Peter Rossing
Current Hypertension Reports|September 3, 2004
Remission and regression of diabetic nephropathyPeter Hovind, Lise Tarnow, Hans-Henrik Parving
Ugeskrift for Laeger|May 19, 2011
[Glyceryl nitrates may cause hypertension]Peter Mørup, Tine Holbæk Levinsen, Peter Hovind
American Journal of Physiology. Cell Physiology|December 18, 2023
The GLP-1-mediated gut-kidney cross talk in humans: mechanistic insightGitte R Hinrichs, Peter Hovind, Ali Asmar
Ugeskrift for Laeger|March 31, 2023
Mads Fich Lønnee, Esben Andreas Carlsen, Peter Hovind
Diabetes Care|March 1, 2003
Smoking and progression of diabetic nephropathy in type 1 diabetesPeter Hovind, Peter Rossing, Lise Tarnow, et al.
Ugeskrift for Laeger|February 18, 2022
[Aksillør lymfeknudesvulst efter vaccination mod COVID-19]Rikke Bannebjerg Baarts Falkentoft, Mads Radmar Jensen, Peter Hovind
Pageof 6